Perkins Coie Trust Company’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,024
Closed -$181K 448
2020
Q1
$181K Buy
1,024
+3
+0.3% +$565 0.09% 93
2019
Q4
$195K Hold
1,021
0.08% 97
2019
Q3
$172K Buy
1,021
+991
+3,303% +$161K 0.08% 96
2019
Q2
$5K Hold
30
﹤0.01% 268
2019
Q1
$4K Hold
30
﹤0.01% 281
2018
Q4
$4K Hold
30
﹤0.01% 279
2018
Q3
$6K Hold
30
﹤0.01% 275
2018
Q2
$5K Sell
30
-65
-68% -$10.4K ﹤0.01% 280
2018
Q1
$16K Hold
95
0.01% 241
2017
Q4
$16K Hold
95
0.01% 236
2017
Q3
$19K Sell
95
-75
-44% -$17.4K 0.01% 232
2017
Q2
$41K Hold
170
0.02% 189
2017
Q1
$41K Hold
170
0.02% 173
2016
Q4
$36K Buy
+170
New +$35.2K 0.02% 184

Other funds holding AGN

Perkins Coie Trust Company's AGN Position: Q2 2020 in Review

Perkins Coie Trust Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,024 shares — an estimated $181K sold.

Perkins Coie Trust Company first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $195K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Perkins Coie Trust Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Perkins Coie Trust Company sold 1,024 Allergan plc shares in Q2 2020, an estimated $181K.
  • Perkins Coie Trust Company first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Perkins Coie Trust Company's Allergan plc position peaked at $195K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Perkins Coie Trust Company's 13F filing for Q2 2020, filed 13 Jul 2020.